Next Generation Dx Summit 2017 | Predicting Responses to Cancer Immunotherapy

from CHI Podcasts · host Cambridge Healthtech Podcasts

Robert Anders of Johns Hopkins Medicine speaks to CHI on May 16th, 2017. Dr. Anders will be speaking during the Biomarkers for Cancer Immunotherapy and Combinations meeting at the Next Generation Diagnostics Summit August 15-18th in Washington DC. Topics include the integration of genomic, proteomic and immunological markers for cancer immunotherapy, challenges in implementing multiplex approaches, and more. For more information, please visit http://www.NextGenerationDx.com/Biomarkers-Cancer-Immunotherapy/

Episode metadata supplied by the publisher feed · Published Jun 2, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

Next Generation Dx Summit 2017 | Predicting Responses to Cancer Immunotherapy

0:00 9:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 9 minutes long.

When was this CHI Podcasts episode published?

This episode was published on June 2, 2017.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!